Clin2
NCT06929702Likely a fitRecruiting

Precision dosing of antibiotics for critically ill children

Amoxicillin-clavulanatePiperacillin-tazobactamMeropenem

Part of Infections clinical trials.

This trial tests a personalized dosing approach for certain antibiotics (amoxicillin-clavulanic acid, piperacillin-tazobactam, and meropenem) in hospitalized children with serious infections. The goal is to adjust the dose based on blood tests to make sure each child gets the right amount of medicine.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 4
Enrollment
58 people
Ages
birth to 18 years
Study type
Interventional

Who can take part

  • Children from newborn up to 17 years 10 months old
  • Admitted to the NICU, PICU, or pediatric hematology-oncology unit
  • Has a confirmed or strongly suspected serious infection
  • Will start one of these IV antibiotics: amoxicillin-clavulanic acid, piperacillin-tazobactam, or meropenem, expected to be given for at least 2 days
  • Not currently on dialysis, ECMO, body cooling, or expected to pass away soon
  • No allergy to the assigned antibiotic and not pregnant

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT02456974Recruiting
Testing how antibiotics are dosed in children’s intensive care

This study looks at whether giving common antibiotics in certain dose schedules (either through a drip over time or continuously) is done in a way that fits pediatric intensive care needs. It may help improve antibiotic treatment for children who are very sick and need antibiotics.

Ghent
NCT06426836Recruiting
Better antibiotic dosing for children on ECMO

This trial studies how to give the right dose of common antibiotics to children on ECMO (a heart-lung bypass machine). The goal is to help doctors choose the best dose to fight infections while keeping the child safe.

Brussels, Brussels Capital
NCT07822243Recruiting
Antibiotic penetration in critically ill children

This study looks at why some antibiotics given through a vein may reach infections differently in very sick children. It aims to make sure medicines are given in the best way to help children in the intensive care unit recover.

Ghent
NCT06766461Recruiting· Phase 4
Optimizing antibiotic dosing in ICU patients with septic shock

This trial checks if giving higher doses of beta-lactam antibiotics (a type of strong antibiotic) right from the start helps people in the ICU with septic shock. It aims to find the best dose to fight the infection quickly.

Rotterdam
NCT07484633Not yet recruiting· Phase 4
Comparing antibiotic infusion methods for children with sepsis

This study compares two ways of giving antibiotics to children with sepsis: the usual short infusions versus longer or continuous infusions. The goal is to see if one approach works better or is safer.

Budapest
NCT07666230Not yet recruiting
Personalized antibiotic dosing for ICU patients

This trial tests a new way to quickly measure antibiotic levels in the blood of ICU patients, so doctors can adjust the dose for each person. It aims to make antibiotic therapy more effective and safer.

Hear when a new Amoxicillin-clavulanate trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.